Literature DB >> 15075323

Interactions between the cartilage oligomeric matrix protein and matrilins. Implications for matrix assembly and the pathogenesis of chondrodysplasias.

Henning H Mann1, Suat Ozbek, Jürgen Engel, Mats Paulsson, Raimund Wagener.   

Abstract

The cartilage oligomeric matrix protein (COMP) and matrilins are abundant non-collagenous proteins in the cartilage extracellular matrix. In the presence of calcium, COMP and matrilin-1 elute together in the gel filtration of cartilage extracts and can be co-immunoprecipitated. In a screen for ligands of matrilin-1, -3, and -4 using an ELISA-style binding assay, COMP was identified as a prominent binding partner for all three, indicating a conservation of the COMP interaction among matrilins. The interaction of COMP and matrilin-4 is saturable, and an apparent K(D) of 1 nm was determined. However, only the full-length COMP and the full-length matrilin-4 proteins showed a strong interaction, indicating that the oligomeric structures markedly increase the affinity. Mutations in COMP or matrilin-3 cause related forms of human chondrodysplasia, and the COMP mutation D469Delta, which is found in patients with pseudoachondroplasia, has been shown to cause a reduced calcium binding. Despite this, the mutation causes only a slight decrease in matrilin-4 binding. This indicates that impaired binding of COMP to matrilins does not cause the pseudoachondroplasia phenotype but rather that matrilins may be coretained in the rough endoplasmatic reticulum where COMP accumulates in the chondrocytes of patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075323     DOI: 10.1074/jbc.M403778200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  73 in total

1.  Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.

Authors:  Kaisa E Happonen; Tore Saxne; Anders Aspberg; Matthias Mörgelin; Dick Heinegård; Anna M Blom
Journal:  Arthritis Rheum       Date:  2010-12

Review 2.  Thrombospondins and novel TSR-containing proteins, R-spondins, regulate bone formation and remodeling.

Authors:  Kurt D Hankenson; Mariya T Sweetwyne; Hailu Shitaye; Karen L Posey
Journal:  Curr Osteoporos Rep       Date:  2010-06       Impact factor: 5.096

3.  Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand.

Authors:  J L Min; I Meulenbelt; N Riyazi; M Kloppenburg; J J Houwing-Duistermaat; A B Seymour; C M van Duijn; P E Slagboom
Journal:  Ann Rheum Dis       Date:  2006-01-05       Impact factor: 19.103

4.  Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes.

Authors:  Thomas M Merritt; Roger Bick; Brian J Poindexter; Joseph L Alcorn; Jacqueline T Hecht
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

5.  Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases.

Authors:  Maryline Fresquet; Thomas A Jowitt; Joni Ylöstalo; Paul Coffey; Roger S Meadows; Leena Ala-Kokko; David J Thornton; Michael D Briggs
Journal:  J Biol Chem       Date:  2007-09-18       Impact factor: 5.157

6.  Proteolytic processing causes extensive heterogeneity of tissue matrilin forms.

Authors:  Harald W A Ehlen; Gerhard Sengle; Andreas R Klatt; Anja Talke; Stefan Müller; Mats Paulsson; Raimund Wagener
Journal:  J Biol Chem       Date:  2009-06-16       Impact factor: 5.157

Review 7.  Fell-Muir Lecture: Proteoglycans and more--from molecules to biology.

Authors:  Dick Heinegård
Journal:  Int J Exp Pathol       Date:  2009-12       Impact factor: 1.925

8.  ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.

Authors:  Chuan-Ju Liu; Wei Kong; Kiril Ilalov; Shuang Yu; Ke Xu; Lisa Prazak; Marc Fajardo; Bantoo Sehgal; Paul E Di Cesare
Journal:  FASEB J       Date:  2006-04-03       Impact factor: 5.191

9.  Ribozyme-mediated reduction of wild-type and mutant cartilage oligomeric matrix protein (COMP) mRNA and protein.

Authors:  Joseph L Alcorn; Thomas M Merritt; Mary C Farach-Carson; Huiqui H Wang; Jacqueline T Hecht
Journal:  RNA       Date:  2009-02-23       Impact factor: 4.942

Review 10.  Disorders of the growth plate.

Authors:  Chanika Phornphutkul; Philip A Gruppuso
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-12       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.